These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease.
    Author: Dover GJ, Charache S.
    Journal: Semin Oncol; 1992 Jun; 19(3 Suppl 9):61-6. PubMed ID: 1379374.
    Abstract:
    In the past 8 years, it has become apparent that some cytotoxic drugs that interfere with DNA replication can reprogram erythroid progenitors to switch from adult hemoglobin to fetal hemoglobin (HbF) production. Hydroxyurea has now been shown to substantially increase HbF in patients with sickle cell anemia. Since HbF interferes with sickle hemoglobin polymerization, hydroxyurea may become an important therapeutic agent for patients with sickle cell anemia.
    [Abstract] [Full Text] [Related] [New Search]